BIOCRYST PHARMACEUTICALS INC (BCRX)
US09058V1035 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to BCRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.09. This target is 238.81% above the current price.
BCRX was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about BCRX.
In the previous month the buy percentage consensus was at a similar level.
BCRX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-01-08 | Needham | Reiterate | Buy -> Buy |
| 2023-11-20 | JP Morgan | Reiterate | Overweight |
| 2023-11-06 | Needham | Reiterate | Buy -> Buy |
| 2023-09-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-18 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2023-08-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-08-04 | Jefferies | Upgrade | Hold -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-03 | Needham | Reiterate | Buy |
| 2023-07-13 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-05-04 | Needham | Reiterate | Buy |
| 2023-05-04 | RBC Capital | Reiterate | Sector Perform |
| 2023-04-20 | Needham | Reiterate | Buy |
| 2023-04-20 | Evercore ISI Group | Maintains | Outperform |
| 2023-03-14 | RBC Capital | Reiterate | Sector Perform |
| 2023-02-22 | JMP Securities | Reiterate | Market Outperform |
| 2023-02-22 | Needham | Upgrade | Hold -> Buy |
| 2023-02-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-02 | RBC Capital | Maintains | Sector Perform |
| 2022-11-02 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2022-08-08 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-08-05 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-08-05 | Barclays | Maintains | Equal-Weight |
| 2022-08-05 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-04-18 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-04-12 | RBC Capital | Maintains | Sector Perform |
| 2022-04-11 | Oppenheimer | Maintains | Outperform |
| 2022-04-11 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-12-10 | Oppenheimer | Initiate | Outperform |